IRIDEX Corporation $IRIX Shares Sold by AMH Equity Ltd

AMH Equity Ltd reduced its holdings in shares of IRIDEX Corporation (NASDAQ:IRIX) by 63.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 190,000 shares of the medical equipment provider’s stock after selling 328,541 shares during the quarter. AMH Equity Ltd owned approximately 1.13% of IRIDEX worth $168,000 as of its most recent filing with the SEC.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of IRIDEX in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, IRIDEX currently has an average rating of “Sell”.

IRIDEX Stock Up 2.9%

Shares of NASDAQ IRIX opened at $1.06 on Friday. The stock has a market cap of $18.01 million, a PE ratio of -3.21 and a beta of 0.59. The company has a quick ratio of 1.34, a current ratio of 1.96 and a debt-to-equity ratio of 62.29. IRIDEX Corporation has a 52-week low of $0.78 and a 52-week high of $1.95. The business has a 50-day moving average price of $1.19 and a 200 day moving average price of $1.13.

IRIDEX (NASDAQ:IRIX) last announced its earnings results on Tuesday, August 12th. The medical equipment provider reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.03. The business had revenue of $13.57 million for the quarter, compared to analysts’ expectations of $13.10 million. IRIDEX had a negative net margin of 10.95% and a negative return on equity of 386.93%.

IRIDEX Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.